Nuvation Bio Inc. Increase (Decrease) in Intangible Assets, Current
Nuvation Bio Inc. (NUVB) reported Increase (Decrease) in Intangible Assets, Current of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Increase (Decrease) in Intangible Assets, Current 6 month $0.00.
- 2025-06-30: Increase (Decrease) in Intangible Assets, Current 6 month $8.00M.
- 2024-06-30: Increase (Decrease) in Intangible Assets, Current 6 month $0.00.
| Period end | Increase (Decrease) in Intangible Assets, Current 6 month |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2025-06-30 | $8.00M 10-Q · filed 2026-08-06 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |